Moreover, in our previous studies, there were significant differences between CXCL8 concentrations and nodal involvement in patients with pancreatic cancer [22], while the serum level of this chemokine was statistically higher in subjects with distant metastases than without them in CRC patients [24]. This evidence concerns the gene CXCL8 and familial pancreatic carcinoma.